BioCentury | Oct 10, 2011
Company News

Cobra Biologics AB supply/service, biomanufacturing news

...minority stake in Cobra Biologics Holding. Terms were not disclosed. Recipharm acquired contract development company Cobra Biomanufacturing plc...
BioCentury | Aug 31, 2009
Company News

Cobra Bio board of directors update

Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Appointed: Daniel Chapchal as non-executive chairman; he replaces Peter Fothergill, who stepped down WIR Staff...
BioCentury | Apr 13, 2009
Clinical News

Cobra Bio preclinical data

...bacterial vector vaccines, with the U.K.'s Ministry of Defence. Data were published in Microbial Pathogenesis. Cobra Biomanufacturing plc...
BioCentury | Jan 28, 2008
Company News

Cobra Bio management update

Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Hired: Simon Saxby as COO and a director, formerly CEO of Alpha Biologics Sdn Bhd Departing: David Thatcher as CEO while remaining a director WIR Staff...
BioCentury | Oct 29, 2007
Company News

Cobra Bio, University of Rochester Medical Center deal

...uses the university's herpes simplex virus (HSV) amplicon vector technology. Further terms were not disclosed. Cobra Biomanufacturing plc...
BioCentury | Oct 22, 2007
Company News

Advaxis, Cobra Bio deal

...trial to treat cervical cancer. Financial terms were not disclosed. Advaxis Inc. (ADXS), Princeton, N.J. Cobra Biomanufacturing plc...
BioCentury | Jun 11, 2007
Company News

Cobra Bio, University of Cambridge, University of London, U.K. Department of Trade and Industry infectious news

...avian influenza and to treat HIV. CBF will own any new bacteria strains and plasmids. Cobra Biomanufacturing plc...
BioCentury | Feb 5, 2007
Company News

Cobra Bio, Pharmexa deal

...against receptor activator of nuclear factor-kappa B ligand ( RANKL ) is in preclinical testing. Cobra Biomanufacturing plc...
BioCentury | Jan 22, 2007
Company News

Cequent, Cobra Bio deal

...for milestones and royalties. Further terms were not disclosed. Cequent Pharmaceuticals Inc. , Cambridge, Mass. Cobra Biomanufacturing plc...
BioCentury | Dec 4, 2006
Company News

Auxilium, Cobra Bio deal

...the compound from BioSpecifics Technologies Corp. (BSTC, Lynbrook, N.Y.). Auxilium Pharmaceuticals Inc. (AUXL), Malvern, Penn. Cobra Biomanufacturing plc...
Items per page:
1 - 10 of 33
BioCentury | Oct 10, 2011
Company News

Cobra Biologics AB supply/service, biomanufacturing news

...minority stake in Cobra Biologics Holding. Terms were not disclosed. Recipharm acquired contract development company Cobra Biomanufacturing plc...
BioCentury | Aug 31, 2009
Company News

Cobra Bio board of directors update

Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Appointed: Daniel Chapchal as non-executive chairman; he replaces Peter Fothergill, who stepped down WIR Staff...
BioCentury | Apr 13, 2009
Clinical News

Cobra Bio preclinical data

...bacterial vector vaccines, with the U.K.'s Ministry of Defence. Data were published in Microbial Pathogenesis. Cobra Biomanufacturing plc...
BioCentury | Jan 28, 2008
Company News

Cobra Bio management update

Cobra Biomanufacturing plc (LSE:CBF), Keele, U.K. Business: Biomanufacturing, Supply/Service Hired: Simon Saxby as COO and a director, formerly CEO of Alpha Biologics Sdn Bhd Departing: David Thatcher as CEO while remaining a director WIR Staff...
BioCentury | Oct 29, 2007
Company News

Cobra Bio, University of Rochester Medical Center deal

...uses the university's herpes simplex virus (HSV) amplicon vector technology. Further terms were not disclosed. Cobra Biomanufacturing plc...
BioCentury | Oct 22, 2007
Company News

Advaxis, Cobra Bio deal

...trial to treat cervical cancer. Financial terms were not disclosed. Advaxis Inc. (ADXS), Princeton, N.J. Cobra Biomanufacturing plc...
BioCentury | Jun 11, 2007
Company News

Cobra Bio, University of Cambridge, University of London, U.K. Department of Trade and Industry infectious news

...avian influenza and to treat HIV. CBF will own any new bacteria strains and plasmids. Cobra Biomanufacturing plc...
BioCentury | Feb 5, 2007
Company News

Cobra Bio, Pharmexa deal

...against receptor activator of nuclear factor-kappa B ligand ( RANKL ) is in preclinical testing. Cobra Biomanufacturing plc...
BioCentury | Jan 22, 2007
Company News

Cequent, Cobra Bio deal

...for milestones and royalties. Further terms were not disclosed. Cequent Pharmaceuticals Inc. , Cambridge, Mass. Cobra Biomanufacturing plc...
BioCentury | Dec 4, 2006
Company News

Auxilium, Cobra Bio deal

...the compound from BioSpecifics Technologies Corp. (BSTC, Lynbrook, N.Y.). Auxilium Pharmaceuticals Inc. (AUXL), Malvern, Penn. Cobra Biomanufacturing plc...
Items per page:
1 - 10 of 33